List of works - Pilar Martinez Martinez

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.

scientific article published on 24 December 2013

A human-specific TNF-responsive promoter for Goodpasture antigen-binding protein.

scientific article

A novel method for making human monoclonal antibodies.

scientific article

Acute and chronic immunomodulatory changes in rat liver after fetal and perinatal asphyxia

scientific article published in April 2014

Altered Sphingolipid Balance in Capillary Cerebral Amyloid Angiopathy.

scientific article published on 21 September 2016

An in vitro and in vivo study of peptide-functionalized nanoparticles for brain targeting: The importance of selective blood-brain barrier uptake

scientific article published on 21 November 2016

Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange

scientific article published on 14 September 2007

Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders

scientific article

Ceramide function in the brain: when a slight tilt is enough.

scientific article published on 24 June 2012

Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient.

scientific article published on 31 October 2017

Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor

scientific article published on 16 January 2014

Complement activation by ceramide transporter proteins

scientific article published on 6 January 2014

DGAT1 overexpression in muscle by in vivo DNA electroporation increases intramyocellular lipid content

scientific article published on 01 December 2004

Delivery of peptide and protein drugs over the blood-brain barrier

scientific article published on 24 January 2009

Detection of Peptide-based nanoparticles in blood plasma by ELISA

scientific article

Erratum: gene-environment interaction research and transgenic mouse models of Alzheimer's disease.

scientific article published on 10 January 2011

Fetal asphyctic preconditioning modulates the acute cytokine response thereby protecting against perinatal asphyxia in neonatal rats.

scientific article published on 26 January 2013

Gene-environment interaction research and transgenic mouse models of Alzheimer's disease

scientific article

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells.

scientific article

Generation of polyclonal antibodies directed against G protein-coupled receptors using electroporation-aided DNA immunization

scientific article published in July 2008

Glycine receptor antibodies in PERM: a new channelopathy

scientific article

Goodpasture antigen-binding protein, the kinase that phosphorylates the goodpasture antigen, is an alternatively spliced variant implicated in autoimmune pathogenesis

scientific article

Goodpasture antigen-binding protein/ceramide transporter binds to human serum amyloid P-component and is present in brain amyloid plaques

scientific article published on 6 March 2012

Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys

scientific article

IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients

scientific article published on 10 December 2016

Immunosuppression of experimental autoimmune myasthenia gravis by mycophenolate mofetil.

scientific article published on 29 July 2008

Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis.

scientific article published on 31 December 2012

M(3) muscarinic receptor expression on suburothelial interstitial cells.

scientific article published on 11 March 2009

M3 Muscarinic Receptor-Like Immunoreactivity in Sham Operated and Obstructed Guinea Pig Bladders

scientific article published in May 2011

MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study.

scientific article

MuSK myasthenia gravis and Lambert-Eaton myasthenic syndrome in the same patient.

scientific article published on 13 March 2012

Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?

scientific article

Neuropathy-induced spinal GAP-43 expression is not a main player in the onset of mechanical pain hypersensitivity

scientific article published on 20 October 2011

Novel neuronal surface autoantibodies in plasma of patients with depression and anxiety

scientific article published on 23 November 2020

Paradoxical increase in TAG and DAG content parallel the insulin sensitizing effect of unilateral DGAT1 overexpression in rat skeletal muscle

scientific article (publication date: 14 January 2011)

Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4.

scientific article published on 25 March 2013

Pleiotropic Effect of Human ApoE4 on Cerebral Ceramide and Saturated Fatty Acid Levels.

scientific article

Proteasome inhibition with bortezomib depletes plasma cells and autoantibodies in experimental autoimmune myasthenia gravis.

scientific article published on 14 January 2011

Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients

scientific article

Proteomic analysis of rat tibialis anterior muscles at different stages of experimental autoimmune myasthenia gravis.

scientific article published on 18 June 2013

Reduced thymic expression of ErbB receptors without auto-antibodies against synaptic ErbB in myasthenia gravis.

scientific article published on 18 December 2010

Silencing of Dok-7 in Adult Rat Muscle Increases Susceptibility to Passive Transfer Myasthenia Gravis

scientific article published in October 2016

Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designs

scientific article published on 18 March 2015

Synthesis, Radiosynthesis, and Preliminary in vitro and in vivo Evaluation of the Fluorinated Ceramide Trafficking Inhibitor (HPA-12) for Brain Applications

scientific article

Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?

scientific article published on December 2012

The auto-antigen repertoire in myasthenia gravis.

scientific article published on August 2010

The expression of the Goodpasture antigen-binding protein (ceramide transporter) in adult rat brain

scientific article published on 23 June 2009

Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigen.

scientific article published on 27 January 2016

Unchanged expression of the ceramide transfer protein in the acute 6-OHDA neurodegenerative model

scientific article published in January 2012

List of works by Pilar Martinez Martinez

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.

A human-specific TNF-responsive promoter for Goodpasture antigen-binding protein.

A novel method for making human monoclonal antibodies.

Acute and chronic immunomodulatory changes in rat liver after fetal and perinatal asphyxia

Altered Sphingolipid Balance in Capillary Cerebral Amyloid Angiopathy.

An in vitro and in vivo study of peptide-functionalized nanoparticles for brain targeting: The importance of selective blood-brain barrier uptake

Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange

Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders

Ceramide function in the brain: when a slight tilt is enough.

Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient.

Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor

Complement activation by ceramide transporter proteins

DGAT1 overexpression in muscle by in vivo DNA electroporation increases intramyocellular lipid content

Delivery of peptide and protein drugs over the blood-brain barrier

Detection of Peptide-based nanoparticles in blood plasma by ELISA

Erratum: gene-environment interaction research and transgenic mouse models of Alzheimer's disease.

Fetal asphyctic preconditioning modulates the acute cytokine response thereby protecting against perinatal asphyxia in neonatal rats.

Gene-environment interaction research and transgenic mouse models of Alzheimer's disease

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells.

Generation of polyclonal antibodies directed against G protein-coupled receptors using electroporation-aided DNA immunization

Glycine receptor antibodies in PERM: a new channelopathy

Goodpasture antigen-binding protein, the kinase that phosphorylates the goodpasture antigen, is an alternatively spliced variant implicated in autoimmune pathogenesis

Goodpasture antigen-binding protein/ceramide transporter binds to human serum amyloid P-component and is present in brain amyloid plaques

Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys

IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients

Immunosuppression of experimental autoimmune myasthenia gravis by mycophenolate mofetil.

Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis.

M(3) muscarinic receptor expression on suburothelial interstitial cells.

M3 Muscarinic Receptor-Like Immunoreactivity in Sham Operated and Obstructed Guinea Pig Bladders

MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study.

MuSK myasthenia gravis and Lambert-Eaton myasthenic syndrome in the same patient.

Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?

Neuropathy-induced spinal GAP-43 expression is not a main player in the onset of mechanical pain hypersensitivity

Novel neuronal surface autoantibodies in plasma of patients with depression and anxiety

Paradoxical increase in TAG and DAG content parallel the insulin sensitizing effect of unilateral DGAT1 overexpression in rat skeletal muscle

Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4.

Pleiotropic Effect of Human ApoE4 on Cerebral Ceramide and Saturated Fatty Acid Levels.

Proteasome inhibition with bortezomib depletes plasma cells and autoantibodies in experimental autoimmune myasthenia gravis.

Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients

Proteomic analysis of rat tibialis anterior muscles at different stages of experimental autoimmune myasthenia gravis.

Reduced thymic expression of ErbB receptors without auto-antibodies against synaptic ErbB in myasthenia gravis.

Silencing of Dok-7 in Adult Rat Muscle Increases Susceptibility to Passive Transfer Myasthenia Gravis

Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designs

Synthesis, Radiosynthesis, and Preliminary in vitro and in vivo Evaluation of the Fluorinated Ceramide Trafficking Inhibitor (HPA-12) for Brain Applications

Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?

The auto-antigen repertoire in myasthenia gravis.

The expression of the Goodpasture antigen-binding protein (ceramide transporter) in adult rat brain

Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigen.

Unchanged expression of the ceramide transfer protein in the acute 6-OHDA neurodegenerative model